Healthy control | TAV + dilation | All BAV | BAV − No AR | BAV − mild AR | BAV − moderate AR | BAV − severe AR | p-value | |
---|---|---|---|---|---|---|---|---|
Group size | 25 | 120 | 510 | 216 | 171 | 87 | 36 | – |
Age (years) | 49 ± 12 | 61.1 ± 10.7□ | 51.5 ± 13.5 | 52.5 ± 14 | 52.2 ± 12.6 | 48.8 ± 13.7 | 48.3 ± 12 | < 0.001 |
BMI | 26 ± 5 | 28.9 ± 5.7 | 27.9 ± 5.6 | 28.1 ± 6.4 | 27.9 ± 5.2 | 27.5 ± 4.3 | 28.3 ± 4.1 | 0.4 |
Female (%) | 24.0 | 21.7 | 24.4 | 35.1∆○◊ | 20.7□ | 11.5□ | 8.3□ | < 0.001 |
LVEF (%) | 56.1 ± 6.2 | 59.1 ± 5.8□ | 60.7 ± 7.9 | 62 ± 7.2*◊ | 60.5 ± 7.7*◊ | 59.8 ± 8.7 | 55.2 ± 9 | < 0.001 |
MAAD (mm) | – | 40.7 ± 3.5 | 42.8 ± 5 | 42.2 ± 4.9 | 43.5 ± 5.2 | 42.9 ± 4.6 | 43.2 ± 4.8 | < 0.001 |
SOV (mm) | – | 42.1 ± 5.1□ | 41.1 ± 4.9 | 40 ± 5 | 41.7 ± 4.7 | 42 ± 4.9 | 42.6 ± 4.2 | < 0.001 |
HR | 64 ± 9 | 64 ± 11 | 69 ± 12 | 68 ± 12 | 69 ± 12 | 69 ± 13 | 69 ± 2 | 0.5 |
CO | 5.3 ± 1.1 | 5.3 ± 1.5□ | 7.8 ± 12.4 | 7.6 ± 15.3 | 6.5 ± 1.9 | 10.4 ± 18 | 9.4 ± 2.4 | 0.04 |
SV | 84.5 ± 16.7 | 84.4 ± 25.5 | 101 ± 33 | 88.7 ± 27∆○◊ | 101 ± 30□○◊ | 117 ± 30*□∆◊ | 140 ± 34*□∆○ | < 0.001 |
LVESV | 67 ± 17.7 | 59.2 ± 20.9 | 69.3 ± 37 | 56.6 ± 27*∆○◊ | 68.9 ± 33□○◊ | 79.6 ± 32.3□∆◊ | 124 ± 57*□∆○ | < 0.001 |
LVEDV | 152 ± 29 | 144 ± 43 | 170 ± 61 | 146 ± 47∆○◊ | 170 ± 53□○◊ | 194 ± 52*□∆◊ | 261 ± 79*□∆○ | < 0.001 |
No AS | – | 120 | 308 | 128 | 106 | 55 | 19 | 0.7 |
Mild AS | – | – | 55 | 19 | 23 | 11 | 2 | 0.4 |
Moderate AS | – | – | 68 | 27 | 19 | 16 | 6 | 0.4 |
Severe AS | – | – | 79 | 42○ | 23 | 5◊□ | 9○ | 0.007 |